Legal Opinion
In re Pharmaceutical Industry Average Wholesale Price Litigation
District Court, D. Massachusetts
Decided November 2, 2007No. M.D.L. No. 1456; Civil Action No. 01-12257-PBSPublishedCited by 5 opinions
1Opinion of the Court
MEMORANDUM AND ORDER
PATTI B. SARIS, District Judge.
I. INTRODUCTION
Demra Jordan, a class member, was the sole objector to the $70 million class settlement of all claims pending against the GlaxoSmithKline (“GSK”) defendants in the average wholesale pricing (“AWP”) multi-district litigation. She has appealed this Court’s final approval of the class settlement. Plaintiffs filed a motion for the imposition of an appeal bond in the amount of $131,700 pursuant to Fed. R.App. P. 7. After a review of the submissions, I ALLOW Plaintiffs’ Motion for an Appeal Bond in the amount of $61,000.
II. BACKGROUND
2Cases cited9 opinions
- United States v. Ilario M.A. ZanninoCourt of Appeals for the First Circuit · 1990
- Devlin v. ScardellettiSupreme Court of the United States · 2002
- In re Pharmaceutical Industry Average Wholesale Price LitigationDistrict Court, D. Massachusetts · 2005
- In Re Pharmaceutical Industry Average Wholesale Price LitigationDistrict Court, D. Massachusetts · 2007
- Casillas-Diaz v. PalauCourt of Appeals for the First Circuit · 2006
4 more not listed; retrieve them via the Exa API.
3Cited by5 opinions
- In re General Electric Co. Securities LitigationDistrict Court, S.D. New York · 2014
- Cobell v. SalazarDistrict Court, District of Columbia · 2011
- In re Polyurethane Foam Antitrust LitigationDistrict Court, N.D. Ohio · 2016
- In Re Pharmaceutical Industry Average WholesaleDistrict Court, D. Massachusetts · 2007
- Muehe v. Boston, City ofDistrict Court, D. Massachusetts · 2022